Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
Patients with the 5q- syndrome and Diamond-Blackfan anemia (DBA) suffer from a severe macrocytic anemia. The 5q- syndrome and DBA are disorders of aberrant ribosome biogenesis (ribosomopathies) and haploinsufficiency of the ribosomal protein genes RPS14 and RPS19, respectively, underlies the anemia...
Príomhchruthaitheoirí: | Boultwood, J, Yip, B, Vuppusetty, C, Pellagatti, A, Wainscoat, J |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2013
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2013) -
Activation of the mTOR signaling pathway by L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2013) -
Activation of the mTOR Signaling Pathway by L-Leucine in RPS14-Deficient Erythroid Cells
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2012) -
Effects of L-leucine in 5q-syndrome and other RPS14-deficient erythroblasts
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2012) -
Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
de réir: Yip, B, et al.
Foilsithe / Cruthaithe: (2012)